Jaguar Health, Inc. — Form D

Jaguar Health, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-06-05. The offering totals $4.4M, of which $4.4M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (75)

Showing 25 of 75 people.

NameRoleLocation
Carol LizakExecutive OfficerSan Francisco, CA
Carol LizakRelated PersonSan Francisco, CA
John Micek IIIDirectorSan Francisco, CA
John Micek IIIRelated PersonSan Francisco, CA
Jonathan WolinExecutive OfficerSan Francisco, CA
Jonathan WolinRelated PersonSan Francisco, CA
Lisa ConteDirectorSan Francisco, CA
Lisa ConteExecutive OfficerSan Francisco, CA
Lisa ContePromoterSan Francisco, CA
Lisa ConteRelated PersonSan Francisco, CA
Anula JayasuriyaDirectorSan Francisco, CA
Anula JayasuriyaRelated PersonSan Francisco, CA
Pravin ChaturvediExecutive OfficerSan Francisco, CA
Pravin ChaturvediRelated PersonSan Francisco, CA
Jonathan SiegelDirectorSan Francisco, CA
Jonathan SiegelRelated PersonSan Francisco, CA
James BochnowskiDirectorSan Francisco, CA
James BochnowskiRelated PersonSan Francisco, CA
Steven KingExecutive OfficerAGOURA HILLS, CA
Steven KingRelated PersonAGOURA HILLS, CA
Serge MartinodExecutive OfficerLouisville, KY
Anula B JayasuriyaDirectorSan Francisco, CA
John KallassyExecutive OfficerFarmington, CT
Ari AzhirDirectorBoston, MA
Greg J DivisDirectorSan Francisco, CA

Other filings by this issuer (43)

Showing 15 of 43 filings.

FiledFormOfferingSold
2026-07-01D$40.8M$40.8M
2026-07-01D$2.0M$2.0M
2025-11-24D$10.8M$10.8M
2025-10-10D$1.0M$1.0M
2025-09-23D$2.4M$2.4M
2025-05-28D$1.5M$1.5M
2023-11-30D$60K$60K
2023-05-11D$1.8M$1.8M
2023-05-11D$1.9M$1.9M
2022-09-23D$7K$7K
2022-09-02D$12.0M$12.0M
2022-07-08D$10.0M$300K
2022-04-26D$51K$51K
2022-04-25D$8K$8K
2022-04-25D$40K$40K

More